Global /Taiwan /Healthcare /Drug Manufacturers - General /1752

Nang Kuang Pharmaceutical Co., Ltd.

1752

• TWSE: 1752 • Delayed

33.50TWD -0.3%

1.06 USD

As of 6 June 2026, Nang Kuang Pharmaceutical Co., Ltd. has a market cap of $107.87M USD, ranking #24998 globally and #1331 in Taiwan. It ranks #2239 in the Healthcare sector, and #812 in the Drug Manufacturers - General industry.

Global Rank

24998

Country Rank

1331

Sector Rank

2239

Industry Rank

812

Key Stats

Market Cap

$107.87MUSD

3.39B TWD

Enterprise Value

$117.9MUSD

3.71B TWD

Revenue (TTM)

$68.74MUSD

2.16B TWD

EBITDA (TTM)

$15.2MUSD

478.06M TWD

Net Income (TTM)

$7.77MUSD

244.41M TWD

EBITDA Margin

22%

Profit Margin

11%

PE Ratio

13.9

PS Ratio

1.6

PB Ratio

1.4

EV/EBITDA

7.7

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yu-Bei Wang open_in_new

Employees

552

Founded

1963

Website

nangkuang.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-5.4%	-6.8%	-8.7%	-14%	-9.9%	-6%	-58%	-16%

News

Markets

Exchange	Ticker	Price	Quotes
Taiwan Stock Exchange (TWSE) MIC: XTAI PRIMARY	1752 南光化學製藥股份有限公司 ISIN: TW0001752004 Shares Out.: Shares Outstanding: 100.988M¹ Shares Float: 80.974M² TV: TradingView: TWSE: 1752 SA: Stock Analysis: TPE: 1752 YF: Yahoo Finance: 1752.TW GF: Google Finance: TPE: 1752 BA: Barron's: 1752 MS: Morningstar: XTAI: 1752	33.50 TWD	TV: TradingView: TWSE: 1752 SA: Stock Analysis: TPE: 1752 YF: Yahoo Finance: 1752.TW GF: Google Finance: TPE: 1752 BA: Barron's: 1752 MS: Morningstar: XTAI: 1752

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nang Kuang Pharmaceutical Co., Ltd.

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in alimentary and metabolism, blood, antineoplastic and immunomodulatory, dermatological, genito-urinary and sex hormone, systemic hormone and antibacterial, cosmetics, and hospital solutions. In addition, the company is involved in trading of pharmaceuticals. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.8B 245.34B TWD 7K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.84B 57.95B TWD 2K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$925.55M 29.11B TWD 758%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$809.3M 25.46B TWD 650%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$789.12M 24.82B TWD 632%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$584.14M 18.38B TWD 442%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 706K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 507K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 334K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 301K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 268K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 257K%	20.5	Switzerland

chevron_leftBack